SPHRF OTC
Starpharma Holdings Limited
1W: +23.4%
1M: +23.4%
3M: +11.5%
YTD: +100.0%
1Y: +480.0%
3Y: +20.8%
5Y: -49.6%
$0.58
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$12M
+145.0% ▲
5Y CAGR: +28.1%
Gross Profit
$10M
+181.4% ▲
Operating Income
-$19M
-60.1% ▼
Net Income
-$7M
+25.4% ▲
EPS (Diluted)
$-0.02
+27.6% ▲
EBITDA
-$18M
-67.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $5M | $4M | $8M | $5M | $12M |
| YoY Growth | +48.0% | -15.9% | +90.9% | -40.7% | +145.0% |
| Cost of Revenue | $3M | $2M | $632K | $1M | $2M |
| Gross Profit | $2M | $1M | $8M | $4M | $10M |
| Gross Margin | 36.9% | 28.1% | 92.4% | 75.1% | 86.3% |
| R&D Expenses | $19M | $19M | $16M | $8M | $22M |
| SG&A Expenses | $7M | $8M | $7M | $3M | $7M |
| Operating Expenses | $20M | $26M | $18M | $16M | $30M |
| Operating Income | -$35M | -$35M | -$11M | -$12M | -$19M |
| Operating Margin | -679.9% | -794.6% | -129.7% | -244.3% | -159.6% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$16M | -$16M | -$8M | -$10M | -$19M |
| Tax Expense | $0 | $0 | $0 | $0 | -$11M |
| Net Income | -$16M | -$16M | -$8M | -$10M | -$7M |
| Net Margin | -312.9% | -360.1% | -98.5% | -203.4% | -62.0% |
| EPS (Diluted) | $-0.04 | $-0.04 | $-0.02 | $-0.02 | $-0.02 |
| EBITDA | -$17M | -$17M | -$10M | -$11M | -$18M |
| Shares Outstanding | 407M | 409M | 411M | 417M | 431M |